Literature DB >> 17430250

How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.

Debomoy K Lahiri1, Bryan Maloney, Md Riyaz Basha, Yuan Wen Ge, Nasser H Zawia.   

Abstract

Alzheimer's disease (AD) is currently the most prominent form of dementia among the elderly. Although AD manifests in late adult life, it is not clear when the disease actually starts and how long the neuropathological processes take to develop AD. The major unresolved question is the timing and the nature of triggering leading to AD. Is it an early or developmental and/or late phenomenon and what are the factors that trigger the cascade of pathobiochemical processes? To explain the etiology of AD one should consider the neuropathological features, such as neuronal cell death, tau tangles, and amyloid plaque, and environmental factors associated with AD, such as diet, toxicological exposure, and hormonal factors. Current dominant theories of AD etiology are "protein-only", they attribute the cause of the disease directly to the activities of associated proteins once they have been produced; the major limitation is that protein aggregations occur "late in the game". Development and progression of AD has not been explained by protein-only models. In view of this limitation, we propose a "Latent Early-Life Associated Regulation" (LEARn) model, which postulates a latent expression of specific genes triggered at the developmental stage. According to this model, environmental agents (e.g., heavy metals), intrinsic factors (e.g., cytokines), and dietary factors (e.g., cholesterol) perturb gene regulation in a long-term fashion, beginning at early developmental stages; however, these perturbations do not have pathological results until significantly later in life. For example, such actions would perturb APP gene regulation at very early stage via its transcriptional machinery, leading to delayed overexpression of APP and subsequently of Abeta deposition. This model operates on the regulatory region (promoter) of the gene and by the effect of methylation at certain sites within the promoter of specific genes. Promoters tend to have both positive and negative regulatory elements, and promoter activity can be altered by changes in the primary DNA sequence and by epigenetic changes through mechanisms such as DNA methylation at CpG dinucleotides or oxidation of guanosine residues. The basis of the LEARn model is that environmental factors, including metals and dietary factors, operate by interfering the interaction of methylated CpG clusters with binding proteins, such as MeCP2 and SP1. The LEARn model may explain the etiology of AD and other neuropsychiatric and developmental disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17430250     DOI: 10.2174/156720507780362164

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  45 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 3.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

4.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

5.  Entangled Matters--Alzheimer's, interiority, and the 'unflattening' of the world.

Authors:  Annette Leibing
Journal:  Cult Med Psychiatry       Date:  2008-06

6.  Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Giovambattista Desideri; Giulia Grossi; Riccardo Urso; Martina Rosticci; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-07-02       Impact factor: 3.397

Review 7.  Epigenetic mechanisms in Alzheimer's disease.

Authors:  Diego Mastroeni; Andrew Grover; Elaine Delvaux; Charisse Whiteside; Paul D Coleman; Joseph Rogers
Journal:  Neurobiol Aging       Date:  2011-04-11       Impact factor: 4.673

Review 8.  Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model.

Authors:  Debomoy K Lahiri; Nasser H Zawia; Nigel H Greig; Kumar Sambamurti; Bryan Maloney
Journal:  Biogerontology       Date:  2008-07-31       Impact factor: 4.277

9.  Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos.

Authors:  Carolyn J Mattingly; Thomas H Hampton; Kimberly M Brothers; Nina E Griffin; Antonio Planchart
Journal:  Environ Health Perspect       Date:  2009-02-22       Impact factor: 9.031

Review 10.  Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Authors:  Parul Bali; Debomoy K Lahiri; Avijit Banik; Bimla Nehru; Akshay Anand
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.